Promising Skin-Cancer Vaccine Fails Key Trial

Try Our New Player
WSJ Live
7.5K
62 views
  • About
  • Export
  • Add to
The failure of a GlaxoSmithKline cancer vaccine in a clinical trial is a setback for a hot area of medicine that seeks to harness the body’s immune system to fight tumors. Jeanne Whalen has details on the News Hub.


Copyright 2013, Dow Jones & Company, Inc.

0 comments